These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10497677)

  • 1. Activated protein C resistance: a study among 60 thromboembolic patients in the Singapore population.
    Lim LC; Tan HH; Lee LH; Tien SL; Abdul Ghafar A
    Ann Acad Med Singap; 1999 Mar; 28(2):252-5. PubMed ID: 10497677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism.
    Haim N; Lanir N; Hoffman R; Haim A; Tsalik M; Brenner B
    Am J Med; 2001 Feb; 110(2):91-6. PubMed ID: 11165549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C).
    Glueck CJ; Wang P; Fontaine RN; Tracy T; Sieve-Smith L; Lang JE
    Am J Cardiol; 1999 Sep; 84(5):549-54. PubMed ID: 10482153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [One Chinese case of F V Leiden mutation associated with APC resistance].
    Wu J; Gu JM; Morrisey JH; Esmon N
    Zhonghua Xue Ye Xue Za Zhi; 1997 Sep; 18(9):453-6. PubMed ID: 15625834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden mutation is not increased in patients with inflammatory bowel disease.
    Zauber NP; Sabbath-Solitare M; Rajoria G; Mogan G
    J Clin Gastroenterol; 1998 Oct; 27(3):215-6. PubMed ID: 9802448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of activated protein C resistance(APC-R) and FV Leiden in healthy blood donors and patients with thrombosis].
    Hong M; Wei W; Song S
    Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):455-7. PubMed ID: 11189481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercoagulability in various autoimmune diseases: no association with factor V Leiden mutation.
    Regéczy N; Balogh I; Lakos G; Zeher M; Bodolay E; Szücs G; Kiss E; Ajzner E; Szegedi G
    Haematologia (Budap); 2000; 30(1):35-9. PubMed ID: 10841323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
    Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
    J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese.
    Irani-Hakime N; Tamim H; Kreidy R; Almawi WY
    Am J Hematol; 2000 Sep; 65(1):45-9. PubMed ID: 10936863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of the factor VLeiden mutation among autopsy patients with pulmonary thromboembolic disease using an improved method for factor VLeiden detection.
    Gorman TE; Arcot AN; Baker P; Prior TW; Brandt JT
    Am J Clin Pathol; 1999 Mar; 111(3):413-7. PubMed ID: 10078118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Factor V Leiden in three ethnic groups of patients with deep vein thrombosis in the Western Cape province of South Africa.
    Rubinstein R; Kolia F; Novitzky N
    Eur J Haematol; 2000 Jul; 65(1):78-9. PubMed ID: 10914945
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study.
    Hainaut P; Azerad MA; Lehmann E; Schlit AF; Zech F; Heusterspreute M; Philippe M; Col C; Lavenne E; Moriau M
    J Intern Med; 1997 May; 241(5):427-33. PubMed ID: 9183312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of factor V Leiden in patients with acute myocardial infarction.
    Gowda MS; Zucker ML; Vacek JL; Carriger WL; Van Laeys DL; Rachel JM; Strope BD
    J Thromb Thrombolysis; 2000 Jan; 9(1):43-5. PubMed ID: 10590188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V:Q506 mutation-resistance to activated protein C (APC): clinical implications with respect to family screening.
    Middeldorp S; van der Meer J
    Semin Thromb Hemost; 1998; 24(4):363-6. PubMed ID: 9763353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden.
    Strandberg K; Stenflo J; Nilsson C; Svensson PJ
    J Thromb Haemost; 2005 Nov; 3(11):2578-80. PubMed ID: 16241958
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden and the common haemochromatosis mutation HFE C282Y: is there an association in familial venous thromboembolic disease?
    MacLean RM; Feeney GP; Bowley SJ; Bowen DJ; Worwood M; Collins PW
    Br J Haematol; 1999 Oct; 107(1):210-2. PubMed ID: 10520044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.